Cervical cancer: open trials in France

32 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Institut Bergonie, Bordeaux · Centre Hospitalier Régional et Universitaire de Brest, Brest · Centre Francois Baclesse, Caen Cedex 5 · Centre D'Oncologie Et de Radiotherapie 37, Chambray-lès-Tours · Centre Hospitalier Et Universitaire de Limoges, Limoges · Assistance Publique Hopitaux de Paris, Paris · Hospices Civils de Lyon, Pierre-Bénite · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Oncopole Claudius Regaud, Toulouse Cedex 9 · Institut Gustave Roussy, Villejuif
Registry updated 2026-11-06
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Centre Leon Berard, Lyon · Institut De Cancerologie De L Ouest, Saint-Herblain Cedex · Institut Universitaire Du Cancer Toulouse-Oncopole, Toulouse Cedex 9
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Gustave Roussy, Villejuif
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Institut Bergonie - Unicancer Nouvelle Aquitaine - Service Oncologie medicale, Bordeaux · CHU Brest - Hopital La Cavale Blanche - service oncologie medicale, Brest · Centre Oscar Lambret - Service Oncologie, Lille · ICM - Institut du Cancer de Montpellier - Val d'Aurelle - CIPP, Montpellier · Centre Hospitalier Lyon Sud - Service oncologie medicale, Pierre-Bénite · Institut Gustave Roussy - Departement d'Innovation Therapeutique et d'Essais Precoces (DITEP), Villejuif
Registry updated 2026-11-04
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · DualityBio Inc.
Institut de Cancerologie de l Ouest - Site Paul Papin - Departement d Oncologie - DÃ©partement d', Angers · Centre Georges François Leclerc, Dijon · Centre Léon Bérard - Oncologie Médicale, Lyon · Institut Paoli Calmettes - Hôpital de jour, Marseille · Fondation Hôpital Saint-Joseph, Paris · Centre Hospitalier Universitaire de Poitiers, Poitiers · Institut De Cancerologie De L Ouest, Saint-Herblain Cedex
Registry updated 2026-10-29
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
CHU Bordeaux, Bordeaux · Centre Georges Franăois Leclerc, Dijon · Hopital Claude Huriez - Chu Lille, Lille · Centre Leon Berard, Lyon · Hăpital de La Timone, Marseille · Chu Nantes - Hătel Dieu, Nantes · Institut Claudius Regaud, Toulouse · ICL - Alexis Vautrin, Vandœuvre-lès-Nancy · Institut Gustave Roussy, Villejuif
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
CHU Besancon, Besancon Cedex · Institut Bergonie, Bordeaux · Centre Hospitalier Universitaire De Bordeaux, Bordeaux Cedex · Centr Georges Francois Leclerc, Dijon · Centre Leon Berard, Lyon · Institut Regional Du Cancer De Montpellier, Montpellier Cedex 5 · Institut Curie, Paris · Centre De Lutte Contre Le Cancer Eugene Marquis, Rennes Cedex · Institut De Cancerologie De L Ouest, Saint-Herblain Cedex · Oncopole Claudius Regaud, Toulouse Cedex 9 · Institut Gustave Roussy, Villejuif
Registry updated 2026-10-26
NCT05581121
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Trial Treatment · Phase 3 · Institut Claudius Regaud
Institut de Cancerologie de L'Ouest, Angers · Institut Bergonie, Bordeaux · Chu Brest, Brest · Centre François Baclesse, Caen · Centre Hospitalier Intercommunal de Créteil, Créteil · Centre Georges François Leclerc, Dijon · CHRU Lille, Lille · Centre Oscar Lambret, Lille · CHU Limoges, Limoges · Centre Leon Berard, Lyon · Institut Paoli-Calmettes, Marseille · ICM Val d'Aurelle, Montpellier · CHU Nîmes, Nîmes · Hôpital Européen Georges Pompidou, Paris · Institut Curie, Paris · Hôpital Lariboisière Saint Louis, Paris · Hôpital Cochin, Paris · Hopital Pitie-Salpetriere, Paris · Hopital Lyon Sud, Pierre-Bénite · Institut Godinot, Reims · Centre Henri Becquerel, Rouen · Institut Curie -site Saint-Cloud, Saint-Cloud · Institut de Cancérologie de l'Ouest, Saint-Herblain · Centre Hospitalier Universitaire La Reunion, Saint-Pierre · CHRU Strasbourg, Strasbourg · Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse · CHRU Tours, Tours · Institut Gustave Roussy, Villejuif
Registry updated 2026-10-13
NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Trial Treatment · Phase 1 · SystImmune Inc.
Centre Leon Berard, Lyon · Groupe Hospitalier Pitie - Salpetriere, Paris · Institut de Cancerologie de Ouest (ICO) - Saint-Herblain, Saint-Herblain · Institut Gustave Roussy, Villejuif
Registry updated 2026-09-21
NCT07821879
Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer
Research · Institut Claudius Regaud
Institut Claudius Regaud, Toulouse
Registry updated 2026-09-16
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer
Trial Treatment · Phase 2 · ARCAGY/ GINECO GROUP
Centre Leon Berard, Lyon · Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris
Registry updated 2026-08-13
NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Marengo Therapeutics, Inc.
Institute Gustave Roussy, Villejuif
Registry updated 2026-08-11
NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Eli Lilly and Company
Institut Bergonie, Bordeaux · Centre Leon Berard, Lyon · Institut Paoli-Calmettes, Marseille · Centre Antoine Lacassagne, Nice Cedex 2 · Oncopole Claudius Regaud, Toulouse · Institut Gustave Roussy, Villejuif
Registry updated 2026-07-07
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Centre Hospitalier Universitaire D'Angers, Angers · Centre Antoine Lacassagne, Nice Cedex 2 · Centre Hospitalier Universitaire de Poitiers, Poitiers · Institut De Cancerologie De Lorraine, Vandouvre Les Nancy · Institut Gustave Roussy, Villejuif
Registry updated 2026-07-06
NCT06147960
Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
Research · Centre Hospitalier Universitaire de Nīmes
CHU de Nîmes, Nîmes
Registry updated 2026-06-22
NCT06967961
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Trial Treatment · Institut Claudius Regaud
Oncopole Claudius Regaud, IUCT-O, Toulouse
Registry updated 2026-06-15
NCT07204535
Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
Research · Centre Paul Strauss
Groupement Hospitalier Sud - Hopital Lyon Sud, Pierre-Bénite · ICANS, Strasbourg
Registry updated 2026-06-04
NCT05642780
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Trial Treatment · Phase 2 · Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
Institut Bergonie, Bordeaux · Centre Francois Baclesse, Caen Cedex 5 · Centre Jean Perrin, Clermont-Ferrand · Centr Georges Francois Leclerc, Dijon · Institut Paoli-Calmettes, Marseille · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Lyon-Sud, Pierre-Bénite · Centre Hospitalier Universitaire de Poitiers, Poitiers
Registry updated 2026-05-19
NCT06254846
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
Trial Treatment · Centre Hospitalier Universitaire de Saint Etienne
Service de Gynécologie Obstétrique - CHU Saint-Etienne, Saint-Etienne
Registry updated 2026-05-06
NCT06527456
Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
Trial Treatment · Centre Hospitalier Intercommunal Creteil
Médecins généralistes dans le bassin de l'UPEC, Créteil
Registry updated 2026-04-14
NCT05286034
Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
Trial Treatment · International Agency for Research on Cancer
Centre Régional de Coordination des Dépistages des Cancers-Centre d'Occitanie, Carcassone
Registry updated 2026-03-27
NCT03017573
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Trial Treatment · Institut Curie
Institut Bergonie, Bordeaux · Centre Oscar Lambret, Lille · Centre Leon Berard, Lyon · Institut Curie, Paris · Institut Curie - Hôpital René Huguenin, Saint-Cloud · Institut de Cancérologie de Lorraine - Nancy, Vandœuvre-lès-Nancy
Registry updated 2026-02-03
NCT06083103
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
Research · Centre Paul Strauss
Institut de Cancérologie Strasbourg Europe, Strasbourg
Registry updated 2026-02-02
NCT07305727
A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
Research · Centre Hospitalier Universitaire de Nīmes
Nîmes University Hospital, Nîmes
Registry updated 2026-01-07
NCT03958240
Deciphering Mechanisms Underlying Cancer Immunogenicity
Trial Treatment · Institut Claudius Regaud
Hopital Rangueil, Toulouse · Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse · Hopital Larrey, Toulouse
Registry updated 2025-09-15

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error